english deutsch
BBC News: Fat busting drug helping diabetics
BBC News reports on European Association for the Study of Diabetes report on efficacy of treating overweight people with diabetes with Xenical.
Diabetes and Xenical
Studies show multiple benefits of Xenical for people with type II diabetes.
Diabetes Monitor
Summarizes rationale of Roche's application to acquire indication for Xenical as adjunct therapy for people with type 2 diabetes.
Diabetes Prevention with Xenical
Study suggests Xenical may prevent diabetes in obese people.
Diabetics Benefit from Xenical
Study shows improved blood sugar control and lipid profiles among people with type II diabetes (1998).
Orlistat in type 2 diabetes
Roche reports that in Xenical study of people with type 2 diabetes, improvements in glycemic control and cardiovascular risk factors were observed, and the need for insulin and oral diabetes medications reduced. (24 May 2002)
Xenical and Heart Disease in Diabetes
Study of people with type II diabetes showed Xenical significantly decreased long-term coronary risk.
Xenical in Diabetes Care
Study results of 1-year program treating obese people with type 2 diabetes with orlistat.
Xenical new treatment indication
Roche site profiles application to USFDA for Xenical as an adjunct to other antidiabetic treatments in overweight or obese patients with type 2 diabetes. (21 March 2001)